Nitrazepam

Nitrazepam is a 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one that is substituted at positions 5 and 7 by phenyl and nitro groups, respectively. It is used as a hypnotic for the short-term management of insomnia and for the treatment of epileptic spasms in infants (West’s syndrome). Among its listed roles, it functions as a anticonvulsant, an antispasmodic drug, a GABA modulator, a sedative and a drug metabolite. It is a 1,4-benzodiazepinone and a C-nitro compound. It is grouped under the following drug class(es): Benzodiazepines, Controlled drug substances, Hypnotics, Schedule IV controlled substances and Sedatives. Its therapeutic use is listed as anticonvulsants, central nervous system (CNS) agents and sleeping drugs. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Benzalin, Mogadon and Neozepam. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 4506.